Physician profile
Lawrence Hurwitz
NPI 1538252945
$1,001.14
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $884 · 2020: $101 · 2021: $16.88.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $294.00 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $126.10 | 2019 | |
| Gilead Sciences, INC. | $122.28 | 2019 | |
| Merck Sharp & Dohme LLC | $92.31 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.81 | 2019 | |
| Pfizer INC. | $47.51 | 2019 | |
| Intercept Pharmaceuticals, INC. | $41.97 | 2019 | |
| Allergan, INC. | $39.38 | 2019 | |
| Ferring Pharmaceuticals INC. | $37.75 | 2019 | |
| Ethicon US, LLC | $33.24 | 2019 | |
| Janssen Biotech, INC. | $22.90 | 2019 | |
| Qol Medical, LLC | $22.63 | 2019 | |
| Concordia Pharmaceuticals INC. | $14.43 | 2019 | |
| Ironwood Pharmaceuticals, INC | $13.90 | 2019 | |
| Braintree Laboratories, INC. | $11.93 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Hurwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.